rs201540919
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_016239.4(MYO15A):c.7069G>A(p.Gly2357Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,611,674 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYO15A | NM_016239.4 | c.7069G>A | p.Gly2357Ser | missense_variant | 34/66 | ENST00000647165.2 | |
MYO15A | XM_017024715.3 | c.7072G>A | p.Gly2358Ser | missense_variant | 32/64 | ||
MYO15A | XM_017024714.3 | c.7009G>A | p.Gly2337Ser | missense_variant | 31/63 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYO15A | ENST00000647165.2 | c.7069G>A | p.Gly2357Ser | missense_variant | 34/66 | NM_016239.4 | P1 | ||
MYO15A | ENST00000578999.1 | n.581G>A | non_coding_transcript_exon_variant | 4/4 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.000309 AC: 47AN: 152090Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000180 AC: 44AN: 244232Hom.: 0 AF XY: 0.000219 AC XY: 29AN XY: 132578
GnomAD4 exome AF: 0.0000898 AC: 131AN: 1459466Hom.: 1 Cov.: 33 AF XY: 0.0000978 AC XY: 71AN XY: 725918
GnomAD4 genome ? AF: 0.000309 AC: 47AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74426
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 25, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 27, 2018 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.7069G>A (p.G2357S) alteration is located in exon 34 (coding exon 33) of the MYO15A gene. This alteration results from a G to A substitution at nucleotide position 7069, causing the glycine (G) at amino acid position 2357 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 17, 2015 | p.Gly2357Ser in exon 34 of MYO15A: This variant is not expected to have clinical significance because the glycine (Gly) residue at position 2357 is not conserve d through species, with 10 mammals having a serine (Ser) at this position. It ha s been identified in 14/104260 chromosomes by the Exome Aggregation Consortium ( ExAC, http://exac.broadinstitute.org; dbSNP rs201540919). - |
Autosomal recessive nonsyndromic hearing loss 3 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 12, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at